Sandbox
TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 28-12-2015
AUM:
₹ 1,324.9 Cr
Expense Ratio
2.1%
Benchmark
NIFTY Pharma TRI
ISIN
INF277K018A5
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Meeta Shetty, Rajat Srivastava
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option | -1.27 | 22.13 | 15.4 |
| Nifty Pharma TRI | 3.34 | 22.28 | 13.85 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
30.2499
Last change
-0.19 (-0.6159%)
Fund Size (AUM)
₹ 1,324.9 Cr
Performance
11.7% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Fund Manager
Meeta Shetty, Rajat Srivastava
Riskometer
HIGH
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 7.75 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 5.65 |
| HEALTHCARE GLOBAL ENTERPRISES LTD EQ | 5.13 |
| ABBOTT INDIA LIMITED EQ | 5.04 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 4.85 |
| IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- | 3.99 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 3.96 |
| RAINBOW CHILDRENS MEDICARE LIMITED EQ | 3.78 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 3.57 |
| AJANTA PHARMA LIMITED EQ NEW FV RS. 2/- | 3.45 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 90.86 |
| Chemicals | 4.14 |